3,3'-二辛硫杂碳菁碘 | 53213-89-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 3,3'-二辛硫杂碳菁碘
• 英文名称: 3-Octyl-2-[3-(3-octyl-1,3-benzothiazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzothiazole;iodide
• 英文别名: 3-octyl-2-[3-(3-octyl-1,3-benzothiazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzothiazole;iodide
• CAS: 53213-89-1
• 化学式: C33H45IN2S2
• 分子量: 660.8
• InChiKey: MYIUORMVYDSCRZ-UHFFFAOYSA-M

物化性质

• 溶解度：
  可溶于DMSO

计算性质

• 辛醇/水分配系数(LogP)：
  7.38
• 重原子数：
  38
• 可旋转键数：
  16
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  60.7
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• BIOMARKER COMPOSITIONS AND METHODS
  申请人：Caris Science Inc.

  公开号：EP2922861A1

  公开（公告）日：2015-09-30
• [EN] BIOMARKER COMPOSITIONS AND METHODS<br/>[FR] COMPOSITIONS DE BIOMARQUEUR ET PROCÉDÉS
  申请人：CARIS SCIENCE INC

  公开号：WO2014082083A1

  公开（公告）日：2014-05-30

  Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease, select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and to determine treatment efficacy. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as vesicles, and nucleic acid-protein complexes. The invention provides methods of assessing microvesicles in a biological sample. The invention also provides an aptamer to a microvesicle surface antigen. The aptamer may be used for therapeutic purposes.
• [EN] BIOMARKER METHODS AND COMPOSITIONS<br/>[FR] MÉTHODES ET COMPOSITIONS D'IDENTIFICATION DE BIOMARQUEURS
  申请人：CARIS SCIENCE INC

  公开号：WO2014193999A2

  公开（公告）日：2014-12-04

  Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease, select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and to determine treatment efficacy. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as microvesicles, and nucleic acid-protein complexes.